(Q43049089)

12 November 2017

title

Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection (English)

1 reference

12 November 2017

11

Yilmaz Cakaloglu

0 references

author name string

Fatih Besisik

1

1 reference

12 November 2017

Cetin Karaca

2

1 reference

12 November 2017

Filiz Akyüz

3

1 reference

12 November 2017

Sibel Horosanli

4

1 reference

12 November 2017

Derya Onel

5

1 reference

12 November 2017

Selim Badur

6

1 reference

12 November 2017

Mehmet Sükrü Sever

7

1 reference

12 November 2017

Ahmet Danalioglu

8

1 reference

12 November 2017

Kadir Demir

9

1 reference

12 November 2017

Sabahattin Kaymakoglu

10

1 reference

12 November 2017

Yilmaz Cakaloglu

11

1 reference

12 November 2017

Atilla Okten

12

1 reference

12 November 2017

language of work or name

1 reference

1 April 2003

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

38

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

506-510

1 reference

Hepatitis B and C and renal failure

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Hepatitis in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Rapid and simple method for purification of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Occult hepatitis B virus infection and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Combination chemotherapy for hepatitis B virus: the final solution?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Hepatitis C virus infection and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Severe evolution of chronic hepatitis C in renal transplantation: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900457-9

7 January 2021

10.1016/S0168-8278(02)00457-9

Identifiers

DOI

1 reference

12 November 2017

1 reference